FDA Adverse Event Injury Summary report: N

ENDURANT STENT GRAFT

MDR report key: 7710369 · Received July 23, 2018

Report

Report Number
2953200-2018-01086
Event Type
Injury
Date Received
July 23, 2018
Date of Event
May 1, 2018
Report Date
October 3, 2018
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

MEDTRONIC RECEIVED THE FOLLOWING INFORMATION FROM THE JOURNAL ARTICLE ENTITLED; SURGICAL SITE AND GRAFT INFECTIONS IN ENDOVASCULAR AND OPEN ABDOMINAL AORTIC ANEURYSM SURGERY JASPER C.M. LANGENBERG, JAN A.J.W. KLUYTMANS, HANS G.W. DE GROOT, GWAN H. HO,1 EELCO J. VEEN, M.G. BUIMER AND LIJCKLE VAN DER LAAN SURGICAL INFECTIONS (2018) VOL 19, 4 DOI: 10.1089/SUR.2017.302. AGE/DATE OF BIRTH: AVERAGE AGE. SEX: AVERAGE GENDER. EXACT DATE OF IMPLANT UNKNOWN. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ENDURANT SENT GRAFT SYSTEMS WERE IMPLANTED IN PATIENTS FOR THE ENDOVASCULAR TREATMENT FOR ABDOMINAL AORTIC ANEURYSMS (AAA) BETWEEN JANUARY 2000 AND DECEMBER 2016. THE FOLLOWING ADVERSE EVENTS WERE REPORTED: SURGICAL SITE AND STENT GRAFT INFECTIONS, REINTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
552201 ENDURANT STENT GRAFT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 74 YR Required Intervention